PA8856101A1 - Derivados de 2-piridin-2-il-pirazol-3(2h)-ona, su preparcion y su aplicacion en terapeutica - Google Patents
Derivados de 2-piridin-2-il-pirazol-3(2h)-ona, su preparcion y su aplicacion en terapeuticaInfo
- Publication number
- PA8856101A1 PA8856101A1 PA20098856101A PA8856101A PA8856101A1 PA 8856101 A1 PA8856101 A1 PA 8856101A1 PA 20098856101 A PA20098856101 A PA 20098856101A PA 8856101 A PA8856101 A PA 8856101A PA 8856101 A1 PA8856101 A1 PA 8856101A1
- Authority
- PA
- Panama
- Prior art keywords
- group
- groups
- heteroarilo
- nr5r6
- arilo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
LA INVENCIÓN SE REFIERE A LOS COMPUESTOS QUE RESPONDEN A LA FÓRMULA(I),EN ESTADODE BASE O DE SAL POR ADICIÓN DE UN ÁCIDO:EN LA CUAL N ES IGUAL A 0,1,2,3 O 4;M ES IGUAL A 0,1 O 2;O ES IGUAL A 0 O 1;X REPRESENTA UN GRUPO-CH2,-CH(R')-,-NH(R')-O UN HETEROÁTOMO SELECCIONADO ENTRE O Y S,QUEDANDO ENTENDIDO QUE R' REPRESENTA UN GRUPO ALQUILO(C1-C5)ALKYLE,ALCOXI(C1-C5),-CH2-ARILO,-C(O)R5 O-COOR5;R1 REPRESENTA UN GRUPO OXO,-COOR5,-W-OH O-W-NR5R6;R2 REPRESENTA UN ÁTOMO DE H O UN GRUPO SELECCIONADO ENTRE LOS GRUPOS(I)ALQUILO(C1-C5),(II)ALCOXI(C1-C5),(III)-COOR5,(IV)-NR5R6,(VI)-SO2-NR3R4,(VII)HETEROARILO EVENTUALMENTE SUSTITUIDOS CON UN GRUPO ALQUILO(C1-C5),(VIII)-W-ARILO,(IX)-W-HETEROARILO,(X)-O-W-ARILO,(XI)-O-W-HETEROARILO Y(XII)-O-W-NR5R6;ENTENDIÉNDOSE QUE R3 Y R4,(I)QUE PUEDEN SER IDÉNTICOS O DIFERENTES,REPRESENTAN,INDEPENDIENTEMENTE UNO DE OTRO,UN ÁTOMO H,UN GRUPO ALQUILO(C1-C5),CICLOALQUILO(C3-C6),ARILO,HETEROARILO,-CH2-HETEROARILO,ALQUIL(C1-C5)-NR5R6,-W-OH O-W-NR5R6;O(II)FORMAN JUNTO CON EL ÁTOMO DE NITRÓGENO QUE LOS PORTA UN GRUPO DE HETEROCICLOALQUILO EVENTUALMENTE SUSTITUIDO CON UNO O VARIOS GRUPOS SELECCIONADOS ENTRE LOS GRUPOS ALQUILO(C1-C5)Y-CH2-ARILO;W ES UN GRUPO ALQUILENO-(C1-C5),EVENTUALMENTE SUSTITUIDO CON UNO O VARIOS GRUPOS HIDROXI;R5 Y R6,QUE PUEDEN SER IDÉNTICOS O DIFERENTES,REPRESENTAN,INDEPENDIENTEMENTE UNO DE OTRO UN ÁTOMO DE HIDRÓGENO O UN GRUPO SELECCIIONADO ENTRE LOS GRUPOS ALQUILO(C1-C5)Y LOS GRUPOS CICLOALQUILO(C3-C6),ASÍ COMO SU PROCEDIMIENTO DE PREPARACIÓN Y SUS APLICACIONES EN TERAPÉUTICA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0807475A FR2940652B1 (fr) | 2008-12-29 | 2008-12-29 | Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one,leur preparation et leur application en therapeutique |
| FR0904091A FR2949468B1 (fr) | 2009-08-28 | 2009-08-28 | Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8856101A1 true PA8856101A1 (es) | 2010-07-27 |
Family
ID=41728182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20098856101A PA8856101A1 (es) | 2008-12-29 | 2009-12-28 | Derivados de 2-piridin-2-il-pirazol-3(2h)-ona, su preparcion y su aplicacion en terapeutica |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US8697731B2 (es) |
| EP (1) | EP2382215B1 (es) |
| JP (1) | JP5865704B2 (es) |
| KR (1) | KR101630475B1 (es) |
| CN (1) | CN102333776B (es) |
| AR (1) | AR074916A1 (es) |
| AU (1) | AU2009334570B2 (es) |
| BR (1) | BRPI0923875A2 (es) |
| CA (1) | CA2748413A1 (es) |
| CO (1) | CO6400145A2 (es) |
| CR (1) | CR20110360A (es) |
| CY (1) | CY1115635T1 (es) |
| DK (1) | DK2382215T3 (es) |
| EA (1) | EA019774B1 (es) |
| EC (1) | ECSP11011164A (es) |
| ES (1) | ES2511917T3 (es) |
| HK (1) | HK1163679A1 (es) |
| IL (1) | IL213790A (es) |
| MA (1) | MA32978B1 (es) |
| MX (1) | MX2011007061A (es) |
| MY (1) | MY155244A (es) |
| NI (1) | NI201100132A (es) |
| NZ (1) | NZ593797A (es) |
| PA (1) | PA8856101A1 (es) |
| PE (1) | PE20120338A1 (es) |
| PL (1) | PL2382215T3 (es) |
| PT (1) | PT2382215E (es) |
| SG (1) | SG172422A1 (es) |
| SI (1) | SI2382215T1 (es) |
| SM (1) | SMT201400157B (es) |
| TN (1) | TN2011000308A1 (es) |
| TW (1) | TWI441828B (es) |
| WO (1) | WO2010076525A1 (es) |
| ZA (1) | ZA201104785B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY155244A (en) | 2008-12-29 | 2015-09-30 | Sanofi Sa | Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof |
| EP2361912A1 (en) * | 2010-02-18 | 2011-08-31 | GenKyoTex SA | Pyrazolo piperidine derivatives as NADPH oxidase inhibitors |
| EP2361911A1 (en) * | 2010-02-18 | 2011-08-31 | GenKyoTex SA | Pyrazolo piperidine derivatives as NADPH oxidase inhibitors |
| JP6126078B2 (ja) * | 2012-03-30 | 2017-05-10 | 第一三共株式会社 | ４−アルカノイルアミノ−３−ピラゾロン誘導体 |
| CN102731384B (zh) * | 2012-07-10 | 2016-04-06 | 南开大学 | 一种6-甲基烟酸叔丁酯的合成方法 |
| ES2660914T3 (es) * | 2013-03-29 | 2018-03-26 | Takeda Pharmaceutical Company Limited | Derivados de 6-(5-hidroxi-1H-pirazol-1-il)nicotinamida y su uso como inhibidores de PHD |
| CN105061316B (zh) * | 2015-07-17 | 2017-12-22 | 苏州大学 | 稠环类化合物、制备方法和用途 |
| CN113072562B (zh) * | 2021-04-06 | 2022-01-14 | 山东大学 | 一种GSK-3β抑制剂及其制备方法与应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3917469A1 (de) * | 1989-05-30 | 1990-12-06 | Bayer Ag | Heterocyclylpyridine |
| DE4023488A1 (de) | 1990-07-24 | 1992-01-30 | Bayer Ag | 1-(pyri(mi)dyl-(2)) -5-hydroxy-pyrazol-mikrobizide |
| US5750088A (en) * | 1993-03-30 | 1998-05-12 | The Dupont Merck Pharmaceutical Company | Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals |
| GB9704762D0 (en) | 1997-03-07 | 1997-04-23 | Zeneca Ltd | Chemical process |
| JP4499721B2 (ja) | 2003-06-30 | 2010-07-07 | ヒフ バイオ，インク． | 化合物、組成物および方法 |
| CN1842332A (zh) * | 2003-06-30 | 2006-10-04 | Hif生物公司 | 化合物、组合物及方法 |
| DE102005019712A1 (de) | 2005-04-28 | 2006-11-09 | Bayer Healthcare Ag | Dipyridyl-dihydropyrazolone und ihre Verwendung |
| PE20071020A1 (es) * | 2006-03-07 | 2007-12-11 | Smithkline Beecham Corp | Compuestos derivados de glicina n-sustituidos como inhibidores de prolil hidroxilasa |
| WO2008047198A1 (en) * | 2006-10-16 | 2008-04-24 | Pfizer Products Inc. | Therapeutic pyrazolyl thienopyridines |
| DE102006050516A1 (de) | 2006-10-26 | 2008-04-30 | Bayer Healthcare Ag | Substituierte Dihydropyrazolone und ihre Verwendung |
| RU2009146851A (ru) * | 2007-05-18 | 2011-06-27 | Байер Шеринг Фарма Акциенгезельшафт (DE) | Гетероарил-замещенные пиразольные производные, которые могут использоваться для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом |
| EP2382205B1 (fr) | 2008-12-29 | 2014-04-23 | Sanofi | Dérivés de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur préparation et leur application en thérapeutique comme activateurs de hif |
| MY155244A (en) | 2008-12-29 | 2015-09-30 | Sanofi Sa | Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof |
-
2009
- 2009-12-24 MY MYPI2011003011A patent/MY155244A/en unknown
- 2009-12-24 JP JP2011542887A patent/JP5865704B2/ja not_active Expired - Fee Related
- 2009-12-24 SG SG2011047529A patent/SG172422A1/en unknown
- 2009-12-24 PL PL09805790T patent/PL2382215T3/pl unknown
- 2009-12-24 EA EA201170900A patent/EA019774B1/ru not_active IP Right Cessation
- 2009-12-24 DK DK09805790.4T patent/DK2382215T3/da active
- 2009-12-24 PE PE2011001291A patent/PE20120338A1/es not_active Application Discontinuation
- 2009-12-24 NZ NZ593797A patent/NZ593797A/xx not_active IP Right Cessation
- 2009-12-24 MA MA34029A patent/MA32978B1/fr unknown
- 2009-12-24 BR BRPI0923875-1A patent/BRPI0923875A2/pt not_active IP Right Cessation
- 2009-12-24 SI SI200931025T patent/SI2382215T1/sl unknown
- 2009-12-24 CA CA2748413A patent/CA2748413A1/fr not_active Abandoned
- 2009-12-24 WO PCT/FR2009/052692 patent/WO2010076525A1/fr active Application Filing
- 2009-12-24 PT PT98057904T patent/PT2382215E/pt unknown
- 2009-12-24 MX MX2011007061A patent/MX2011007061A/es active IP Right Grant
- 2009-12-24 AU AU2009334570A patent/AU2009334570B2/en not_active Ceased
- 2009-12-24 EP EP09805790.4A patent/EP2382215B1/fr active Active
- 2009-12-24 CN CN200980157589.3A patent/CN102333776B/zh not_active Expired - Fee Related
- 2009-12-24 KR KR1020117017677A patent/KR101630475B1/ko active IP Right Grant
- 2009-12-24 ES ES09805790.4T patent/ES2511917T3/es active Active
- 2009-12-28 TW TW098145333A patent/TWI441828B/zh not_active IP Right Cessation
- 2009-12-28 AR ARP090105127A patent/AR074916A1/es unknown
- 2009-12-28 PA PA20098856101A patent/PA8856101A1/es unknown
-
2011
- 2011-06-17 TN TN2011000308A patent/TN2011000308A1/fr unknown
- 2011-06-23 CR CR20110360A patent/CR20110360A/es unknown
- 2011-06-27 EC EC2011011164A patent/ECSP11011164A/es unknown
- 2011-06-27 IL IL213790A patent/IL213790A/en not_active IP Right Cessation
- 2011-06-28 ZA ZA2011/04785A patent/ZA201104785B/en unknown
- 2011-06-28 NI NI201100132A patent/NI201100132A/es unknown
- 2011-06-29 CO CO11081313A patent/CO6400145A2/es active IP Right Grant
- 2011-06-29 US US13/172,321 patent/US8697731B2/en not_active Expired - Fee Related
-
2012
- 2012-05-02 HK HK12104300.3A patent/HK1163679A1/xx not_active IP Right Cessation
-
2014
- 2014-03-07 US US14/200,698 patent/US9359329B2/en not_active Expired - Fee Related
- 2014-10-16 CY CY20141100849T patent/CY1115635T1/el unknown
- 2014-10-29 SM SM201400157T patent/SMT201400157B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8856101A1 (es) | Derivados de 2-piridin-2-il-pirazol-3(2h)-ona, su preparcion y su aplicacion en terapeutica | |
| NI201000130A (es) | Derivados de urea de tetrahidroquinoxalina, su preparación y su aplicación en terapéutica. | |
| AR092568A1 (es) | Derivados triciclicos de quinolinas y de quinoxalinas | |
| NI201000049A (es) | Método para producir 2'-desoxi-5-azacitidina (decitabina) | |
| AR106247A2 (es) | Compuestos intermediarios para microbiocidas | |
| AR105640A1 (es) | Derivados heterobicíclicos microbicidas | |
| PA8797301A1 (es) | Derivados de nicotinamida, su preparacion y su aplicacion en terapeutica | |
| CL2008002703A1 (es) | Compuestos derivados de 1,4-dihidro-2h-piridazin-3-ona; composicion herbicida que comprende a dichos compuestos; metodo de control de malezas; uso de dichos compuestos para el control de malezas; y compuestos intermediarios. | |
| ECSP099395A (es) | Nuevos derivados de los ácidos amino-nicotínico y amino-isonicotínico | |
| CO6220974A2 (es) | Derivados de indol 2-carboxamidas y de azaindol 2- carboxamidas sustituidos con un grupo silanilo su preparacion y su aplicacion en terapeutica | |
| AR119494A1 (es) | DERIVADOS DE 6,7-DIHIDRO-5H-PIRIDO[2,3-c]PIRIDAZIN-8-ILO, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SUS USOS COMO AGENTES PROAPOPTÓTICOS | |
| AR059184A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion en tarapeutica | |
| AR066107A1 (es) | Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen. | |
| AR075243A1 (es) | Derivados del 1-fenil-2-piridinil alquil alcohol como inhibidores de fosfodiesterasa | |
| NI200900037A (es) | Derivados de 2-aril-6-fenil-imidazo[1,2-alfa] piridinas, su preparación y su aplicación en terapéutica. | |
| AR080314A1 (es) | Derivado de 1,3,4,8-tetrahidro-2h-pirido (1,2-a) pirazina y su uso como inhibidor de la hiv integrasa | |
| AR082004A1 (es) | Compuestos de fusion de piridina | |
| DOP2010000213A (es) | Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapeutica | |
| CO6290690A2 (es) | Derivados de la 6-cicloamino-3-(piridazin-4-il)imidazo[1,2-b]-piridazina su preparacion y su aplicacion en terapeutica | |
| CO6300861A2 (es) | Compuestos inhibidores de dipeptidil peptidasa iv metodos de preparacion de los mismos y composiciones farmaceuticas que los contienen como agentes activos | |
| ES2626801T3 (es) | Compuestos de triazolopiridina como inhibidores de pde10a | |
| AR082111A1 (es) | Furopiridinas o tienopiridinas condensadas, composiciones farmaceuticas que las contienen utiles para tratar trastornos psicoticos y del sistema nervioso central, y metodo de preparacion de las mismas | |
| AR091185A1 (es) | Derivados de 1,2,4-triazol | |
| ES2603931T3 (es) | Compuestos de triazolo | |
| UY33049A (es) | Derivados de piridino-piridinonas, su preparación y su aplicación en terapéutica |